Clinical Trial Update: Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing plerixafor to G-CSF in WHIM syndrome has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections
• Myelokathexis

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)
• Plerixafor (Plerixafor)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Myelokathexis, Infections | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-04-07